Viral disease outcomes are indistinguishable between experimentally infected bats and rodents

A comprehensive meta-analysis of 86 years of experimental infection data reveals that bats suffer from viral diseases with severity and mortality rates indistinguishable from rodents, challenging the prevailing hypothesis that bats possess a unique, disease-tolerant immunity that makes them exceptional reservoirs for zoonotic viruses.

The Gist

The Great Bat Immunity Myth: A Tale of Superheroes and Regular Folk

Imagine a popular superhero movie where the main character, Bats, is portrayed as having "superpowers." The story goes that these creatures can carry deadly viruses (like Ebola or Nipah) in their bodies without ever getting sick, while humans and other animals would die instantly. Because of this, scientists have been on a treasure hunt, hoping to find the "magic bullet" in bat blood that could cure all human diseases.

But a new study by researchers at the University of Glasgow is like a reality check. They looked at 86 years of scientific experiments to see if this "superpower" story is actually true.

The Big Experiment: Bats vs. Rodents

To test the myth, the researchers didn't just look at bats; they compared them to Rodents (like mice and rats). Why rodents? Because they are also famous for carrying viruses, but they live fast, die young, and don't have the "superpower" of flight. If bats really had special, universal immunity, they should handle viruses much better than rodents.

The team gathered data from over 5,600 animals and 54 different viruses. They looked at what happened when scientists injected these animals with viruses in a lab setting.

The Results: No Superpowers Found

Here is the plot twist: Bats and rodents got sick at almost exactly the same rate.

• The "Superpower" Myth: People thought bats were like immune shields, shrugging off viruses that would kill others.
• The Reality: When you put a bat and a mouse in a lab and give them the same virus, they both get sick, and both have a similar chance of dying.

Think of it like this: If you give a "superhero" and a "regular person" the same cold virus, you might expect the superhero to sneeze once and be fine, while the regular person gets bedridden. But in this study, both the bat and the rodent ended up with the same level of "bedridden-ness."

Why Did We Think Bats Were Special?

So, why did everyone believe the myth for so long? The authors suggest three reasons:

1. The "Survivor Bias" Trap: In the wild, we only see the bats that survive. If a bat gets a virus and dies, it's small, hides in a cave, and no one finds the body. We only see the ones that lived, so it looks like they never get sick. It's like judging a car's safety only by looking at the cars that made it to the finish line, ignoring the ones that crashed and were towed away.
2. The "Famous Villains" Effect: We know bats carry scary viruses like Ebola. Because these viruses are so deadly to humans, we assumed the bats must have some incredible defense against them. But the study shows that while bats can carry these viruses, they don't necessarily have a special shield against all viruses.
3. The "Flight" Theory: Some scientists thought that because flying burns so much energy, bats evolved a super-strong immune system to handle the stress, which accidentally made them immune to viruses. The study suggests that while this might be true for some specific viruses, it's not a universal "force field."

The Real Rules of the Game

The study found that whether an animal gets sick depends on three main things, not on whether it's a bat or a mouse:

• The Virus Type: Some viruses are "specialists" (they only infect one type of animal) and are very dangerous. Others are "generalists" (they infect many types) and are usually milder.
• The Match: If a virus meets a host it has evolved with for a long time (like a bat and a bat-virus), they might get along okay. But if a virus meets a host it has never seen before (like a bat and a human virus), it often causes a disaster. This happens to both bats and rodents.
• The Lab Setup: How much virus was injected? How was it injected? These factors mattered more than the animal's species.

What This Means for the Future

This doesn't mean bats are useless for science. It just means we need to stop looking for a "magic wand" that cures everything.

• The Good News: We can still learn from bats. Maybe they have specific tricks for specific viruses (like how a lock and key fit together).
• The Bad News: We probably won't find a single "bat potion" that makes humans immune to all viruses.
• The Lesson: We need to stop treating bats as magical creatures and start treating them as just another animal in the ecosystem. They are not invincible; they just play by the same rules of nature as the rest of us.

In a Nutshell:
Bats aren't the immune superheroes we thought they were. They are just regular mammals that, like mice, can get very sick from viruses. The idea that they are naturally immune to everything is a myth born from missing data and wishful thinking. To find cures for the future, we need to look at the specific details of how viruses and hosts interact, rather than hoping for a magical bat superpower.

Technical Summary

1. Problem Statement and Background

• The Prevailing Hypothesis: There is a widespread scientific and public perception that bats possess unique immune mechanisms allowing them to coexist with viruses without suffering overt disease (high viral tolerance). This belief is often attributed to the energetic demands of flight, which may have selected for dampened inflammatory responses.
• The Gap: This hypothesis has driven research into bat immune systems as potential sources for broad-spectrum antivirals. However, whether bats actually suffer less disease than other mammals (specifically rodents, another major zoonotic reservoir) has not been formally assessed using systematic, quantitative data.
• The Question: Do bats exhibit superior "tolerance" (limiting disease at a given pathogen load) compared to rodents, both for viruses that have co-evolved with them and for evolutionarily novel viruses?

2. Methodology

The authors conducted a meta-analysis synthesizing 86 years (1936–2022) of experimental viral infection literature.

• Dataset Scope:
  • 112 studies involving 54 viruses (from 15 viral families, 53 RNA, 1 DNA).
  • 85 host species (bats and rodents).
  • 5,622 inoculated animals (149 host-virus pairs).
  • Exclusion: Laboratory-bred rodents were excluded to ensure immune competency comparable to wild counterparts.
• Metrics Defined:
  • Tolerance: Operationally defined as the extent of author-reported disease (clinical and sub-clinical) and mortality following experimental inoculation, assuming hosts were susceptible.
  • Outcomes: Three distinct metrics were analyzed: (1) Disease presence, (2) Mortality, and (3) Disease severity (a 5-point scale from no disease to death).
• Statistical Approach:
  • Hierarchical Bayesian Models: Used to account for non-independence among taxa (phylogeny) and variation in experimental designs.
  • Predictors:
    • Host Order: Bat (Chiroptera) vs. Rodent (Rodentia).
    • Eco-evolutionary Traits: Viral host range (generalist vs. specialist), Host Evolutionary Isolation (HEI), and reservoir match (homologous vs. heterologous inoculations).
    • Experimental Design: Inoculation dose (normalized by body mass), route of inoculation, number of individuals, and viral passage history.
  • Comparative Analysis: Human Case Fatality Rates (CFR) were used as a proxy for viral pathogenicity to test if bats were systematically exposed to more lethal viruses in experiments.

3. Key Contributions

• First Quantitative Synthesis: This is the first large-scale, systematic analysis comparing disease outcomes between bats and rodents across a broad phylogenetic and viral spectrum.
• Refutation of "Generalized Tolerance": The study challenges the notion that bats have evolved a "one-size-fits-all" mechanism to tolerate all viruses due to flight-related life history traits.
• Contextualizing Co-evolution: It distinguishes between "generalized tolerance" (tolerating any virus) and "heightened co-evolutionary tolerance" (tolerating specific co-evolved viruses better than other hosts), finding no evidence for either in the aggregate data.
• Identification of Bias: The paper highlights how experimental design choices (e.g., dose, sample size, inoculation route) and the selection of highly pathogenic viruses (like Ebola/Marburg) in bat studies may have skewed the perception of bat tolerance.

4. Key Results

• Indistinguishable Outcomes:
  • There was no statistically significant difference in disease presence, mortality, or severity between bats and rodents. The 80% credible intervals for the effect of host order included zero.
  • This lack of difference held true when analyzing:
    • All viruses combined.
    • Only bat-associated viruses inoculated into bats vs. rodent-associated viruses in rodents.
    • Heterologous (novel) infections.
• Viral Host Range Matters:
  • Specialist viruses (those infecting a narrow range of hosts) caused more severe disease than generalist viruses (those infecting diverse hosts), consistent with the hypothesis that generalism incurs a fitness cost reducing virulence in any single host.
• Co-evolutionary Context:
  • Host Evolutionary Isolation (HEI): Inoculations into hosts phylogenetically distant from known reservoirs tended to result in more severe disease (suggesting maladaptive virulence), but this effect was not specific to bats.
  • Reservoir Match: There was no strong evidence that bats tolerated their own reservoir viruses better than rodents tolerated theirs.
• Human CFR Correlation:
  • While experiments on bats often used viruses with higher human Case Fatality Rates (CFR) (e.g., Filoviruses, Henipaviruses), bats did not consistently show reduced disease severity compared to rodents when controlling for these factors.
  • Notably, non-bat-associated viruses with low human CFR (e.g., Flaviviruses, Alphaviruses) frequently caused severe or lethal disease in bats, contradicting the idea of universal bat tolerance.
• Experimental Artifacts:
  • Disease detection was positively associated with the number of inoculated individuals (suggesting many studies are underpowered).
  • Higher inoculation doses and direct brain inoculation (more common in bat studies) increased disease severity, but these factors did not explain the lack of a host-order effect.

5. Significance and Implications

• Biomedical Research: The findings suggest that bats are not an unusually rich source of "broad-spectrum" antiviral breakthroughs derived from a generalized tolerance mechanism. While specific bat immune features (e.g., ASC2) may still hold therapeutic value for specific viral clades, the expectation that bats possess a unique, universal shield against viral disease is unsupported by experimental data.
• Ecological Understanding: The results align with conventional evolutionary theory: vertebrate immune systems are tuned to tolerate co-evolved viruses but often fail against novel ones. Bats are not an exception to this rule.
• Future Directions:
  • Research should focus on context-dependent interactions rather than assuming taxon-wide traits.
  • Future experimental designs need larger sample sizes and standardized dosing to avoid underpowered conclusions.
  • There is a critical data gap regarding the inoculation of bat-associated viruses into rodents and vice versa, which is necessary to fully disentangle host-specific vs. virus-specific effects.
• Communication: The paper urges a shift in scientific narrative to avoid over-extrapolating from a few well-studied systems (like Henipaviruses) to the entire order of Chiroptera, emphasizing the need for rigorous quantitative baselines in host-pathogen research.

Conclusion: The study concludes that disease outcomes in bats are "unexceptional" compared to rodents. The perception of bat tolerance is likely a result of observational biases, the specific nature of high-profile zoonotic viruses, and the difficulty of observing morbidity in wild, small mammals, rather than a unique, order-wide biological adaptation.